-+ 0.00%
-+ 0.00%
-+ 0.00%

Nasus Pharma H1 EPS $(0.54) Misses $(0.20) Estimate

Benzinga·08/17/2026 12:15:47
Listen to the news
Nasus Pharma (AMEX:NSRX) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.20) by 170 percent. This is a 217.65 percent decrease over losses of $(0.17) per share from the same period last year.